JACOB ASSET MANAGEMENT OF NEW YORK LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
JACOB ASSET MANAGEMENT OF NEW YORK LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$116,137
-17.2%
4,829
+9.9%
0.16%
+3.8%
Q2 2023$140,300
+2.6%
4,394
-1.6%
0.16%
-0.6%
Q1 2023$136,749
-21.7%
4,4660.0%0.16%
-25.4%
Q4 2022$174,665
-11.3%
4,466
+8.0%
0.21%
-0.5%
Q3 2022$197,000
+34.0%
4,137
+8.8%
0.21%
+43.6%
Q2 2022$147,000
-14.5%
3,804
+27.1%
0.15%
+41.9%
Q1 2022$172,0002,9940.10%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders